<DOC>
	<DOCNO>NCT00495950</DOCNO>
	<brief_summary>The goal study measure amount limb swell ( lymphedema ) sometimes occur melanoma treatment , find people feel react diagnosis treatment melanoma .</brief_summary>
	<brief_title>Prospective Measurement Post-Treatment Lymphedema</brief_title>
	<detailed_description>If choose take part study , measurement take arm legs use Perometer bioimpedance machine . The Perometer machine painlessly measure fluid limb use two-directional infrared light . These light locate frame machine encircles arm leg measurement . The bioimpedance machine measure fluid arm leg pass small current body similar electrocardiogram ( EKG ) . These small current locate electrode place hand foot measurement . Both machine able pick change limb size . You also ask complete set questionnaire relate symptom may experience limbs and/or trunk ( chest , stomach , hip area ) follow standard cancer treatment . Additional questionnaire , along limb measurement , do regularly-scheduled follow-up clinic visit , 3-6 month , 9-12 month , 15-18 month , 21-24 month 27- 30 month . You complete additional questionnaire use laptop computer hardcopy . The measurement questionnaire take 45-60 minute complete time . Some data study may send University Missouri analysis . The data send personal identifier . Researchers University Missouri able link data protect health information personal identity individual participant . This investigational study . Up 350 patient take part study . All patient enrol MD Anderson .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<criteria>1 . Patients confirm diagnosis ( M.D . Anderson pathology ) invasive cutaneous melanoma ( stage IIII ) recruit participation present initial clinical evaluation University Texas M.D . Anderson Melanoma Skin Center . 2 . Prior surgical treatment 3 . Patients knowledgeably voluntarily provide informed consent participate . The informed consent sign date . 4 . Fluent English . 5 . At least 18 year age . 1 . Patients prior history lymphedema melanoma prior treatment . 2 . Patients unable consent due medical illness disorientation person , place time . 3 . Patients know distant metastatic disease ( Stage IV ) . 4 . Patients implanted device ( pace maker ) , orthopedic implant , metal frame . 5 . Presence concurrent malignancy require active treatment , chemotherapy biotherapy , prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Lymphedema</keyword>
	<keyword>Limb Swelling</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Physical Function</keyword>
	<keyword>Survey</keyword>
</DOC>